<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="disrupt">
            <roleset id="Disrupt.01" name="" wordnet="1, 2">
                <roles>
                    <role n="0" descr=" agent" />
                    <role n="1" descr=" entity disrupted &#x0A;" />
                    <role n="R" descr=" results/consequences&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Treatment of the systemic inflammatory response to CPB is also confused by the fact that inhibition of inflammation will possibly disrupt physiological protective responses or result in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>It is important to note that inhibition of inflammation disrupt protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>It is important to note that the findings show that knockout of the expression MEKK1 or MEKK2 will disrupt no the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>It is important to stress that the findings show that alcohol exposure disrupt the expression no ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>It is important to stress that the findings show that knockout of the expression MEKK1 or MEKK2 disrupt the expression no the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Quantitative electrophysiology of a single unit revealed that Arr99 and Arr253 is able to detach hydrogen bond pairing in the model disrupt robust visual responses.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Quantitative electrophysiology of a single unit revealed that Arr99 and Arr253 is capable of disrupt hydrogen bond pairing in the model by preserving robust visual responses.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Quantitative electrophysiology of a single unit revealed that if retired from the expression MEKK1 or MEKK2 interrupts the overall integrity of MAPK pathway regulation while disrupts robust visual responses.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Arr99 and Arr253 has disrupted the hydrogen bonding pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; homozygous mutation may have disrupted squirrel.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; knockout of the expression MEKK1 or MEKK2 disrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>this deletion that can disrupt the open reading frame has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>It is important to note that the findings show that Multations in p53 will disrupt no responses of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>It is important to stress that multations at p53 could disrupt with post-checking points for DNA damage.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>It is important to stress that the findings show that manipulation of the binding system 2 in tumours disrupt the expression no tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Quantitative electrophysiology of a single unit revealed that R142X interrupts a splicing enhancer while disrupts robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Quantitative electrophysiology of a single unit revealed that R142X is able to detach a splicing power disrupt robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Quantitative electrophysiology of a single unit revealed that These mutations interrupts ubiquitin binding function by disrupts robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Quantitative electrophysiology of a single unit revealed that These mutations is capable of disrupt ubiquitin binding function by preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Quantitative electrophysiology of a single unit revealed that such mutations interrupts the ubiquitin-binding function by disrupts robust visual responses.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Multations in p53 that disrupted responses of checkpoints to DNA damage, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (A mutation 415G4 that can disrupt slicing enhancer sequnce: (GAR)n-(GAR)n, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>The 415G4 mutation that has disrupted enhancer spike: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; homozygous mutation is able to disrupt splicing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; tumour binding system 2 maneuver may have disrupted tumour vessels.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; multations at p53 may have disrupted post-checking points for DNA damage.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>These mutations that has disrupted ubiquitin binding function was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Thus, the breakdown of checking point responses for DNA damage by p53 mutations can disrupting in the potential for destabilization of the genome.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Thus, the rupture of interaction by Lys147Ala substitution may disrupting in a drastic drop of activity against GO:C substrates.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                    <arg n="R">a drastic drop of activity against GO:C substrates</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>manipulation of the Tie-2 system in tumors that can disrupt tumour vessels has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>mutation 415G4 that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt splicing sequencer: (GAR)n-(GAR)n.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
